We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated System Developed for Human Organoid Production

By LabMedica International staff writers
Posted on 30 May 2018
An automated liquid handling system has been established for the rapid production of human organoids derived from pluripotent stem cells.

Organoids derived from human pluripotent stem cells are a potentially powerful tool for use in cellular research utilizing high-throughput screening (HTS), but the complexity of maintaining organoid cultures has posed a significant challenge for miniaturization and automation.

In order to simplify working with organoids, investigators at the University of Washington School of Medicine (Seattle, USA) developed a fully automated, HTS-compatible platform for enhanced differentiation and phenotyping of human kidney organoids. More...
This system relied on liquid-handling robots to seed pluripotent stem cells onto 384-well microtiter plates. Each microwell eventually generated ten or more organoids. The entire 21-day protocol, from plating to differentiation to analysis, was performed automatically by liquid-handling robots.

The investigators reported in the May 17, 2018, online edition of the journal Cell Stem Cell that high-content imaging analysis revealed both dose-dependent and threshold effects during organoid differentiation. Immunofluorescence and single-cell RNA sequencing identified previously undetected parietal, interstitial, and partially differentiated compartments within organoids and defined conditions that greatly expanded the vascular endothelium.

In an extension of the protocol, the investigators produced genetically engineered organoids carrying mutations that caused polycystic kidney disease, a common, inherited condition that affects one in 600 people worldwide and often leads to kidney failure. Screening these gene-edited organoids in this system revealed an unexpected role for myosin in polycystic kidney disease.

"This is a new "secret weapon" in our fight against disease," said senior author Dr. Benjamin Freedman, assistant professor of medicine at the University of Washington School of Medicine. "Ordinarily, just setting up an experiment of this magnitude would take a researcher all day, while the robot can do it in 20 minutes. On top of that, the robot does not get tired and make mistakes. "There is no question. For repetitive, tedious tasks like this, robots do a better job than humans."

"These findings give us a better idea of the nature of these organoids and provide a baseline from which we can make improvements," said Dr. Freedman. "The value of this high-throughput platform is that we can now alter our procedure at any point, in many different ways, and quickly see which of these changes produces a better result."

Related Links:
University of Washington School of Medicine


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Uric Acid Meter
PA-16
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.